• 8577 Citations
1985 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Specializing in Genitourinary Oncology.

Areas of Clinical Interest

Oncology, genitourinary oncology, solid tumor oncology, cancer, medical oncology, testicular cancer, germ cell tumors, kidney cancer, renal cell carcinoma, bladder cancer, and renal pelvis tumors.

Fingerprint Dive into the research topics where Bruce Roth is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Open Access
  • 7 Scopus citations

    Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer

    Fischer-Valuck, B. W., Michalski, J. M., Mitra, N., Christodouleas, J. P., DeWees, T. A., Kim, E., Smith, Z. L., Andriole, G. L., Arora, V., Bullock, A., Carmona, R., Figenshau, R. S., Grubb, R. L., Guzzo, T. J., Knoche, E. M., Malkowicz, S. B., Mamtani, R., Pachynski, R. K., Roth, B. J., Zaghloul, M. S. & 2 others, Gay, H. A. & Baumann, B. C., Jul 2019, In : Cancer medicine. 8, 8, p. 3698-3709 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations

    Management of Clinical Stage I Germ Cell Tumors

    Roth, B. J., Aug 2019, In : Urologic Clinics of North America. 46, 3, p. 353-362 10 p.

    Research output: Contribution to journalReview article

  • Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial

    Wong, Y. N., Manola, J., Hudes, G. R., Roth, B. J., Moul, J. W., Barsevick, A. M., Scher, R. M., Volk, M. J., Vaughn, D. J., Williams, S. D., Fisch, M. J., Cella, D., Carducci, M. A. & Wilding, G., Apr 2018, In : Clinical Genitourinary Cancer. 16, 2, p. e315-e322

    Research output: Contribution to journalArticle

  • Quality of life outcomes for cabozantinib versus everolimus in patients with metastatic renal cell carcinoma: METEOR phase III randomized trial

    Cella, D., Escudier, B., Tannir, N. M., Powles, T., Donskov, F., Peltola, K., Schmidinger, M., Heng, D. Y. C., Mainwaring, P. N., Hammers, H. J., Lee, J. L., Roth, B. J., Marteau, F., Williams, P., Baer, J., Mangeshkar, M., Scheffold, C., Hutson, T. E., Pal, S., Motzer, R. J. & 1 others, Choueiri, T. K., Mar 10 2018, In : Journal of Clinical Oncology. 36, 8, p. 757-764 8 p.

    Research output: Contribution to journalArticle

  • 14 Scopus citations